• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

China

 Large layoffs of employees Wooden figures of people going to the exit
MedTech

Retractable Technologies trims staff to save $2.2M annually

Retractable Technologies is cutting roughly 16% of its workforce in a cost-saving move to reduce overhead by $2.2 million a year.
Joseph Keenan Apr 13, 2026 8:20am
cancer target detection radiopharma radio

China’s Oricell raises $110M for CAR-T plans ahead of IPO push

Apr 10, 2026 4:11am
Makary
Favicon Fierce Pharma

FDA's Makary shares policy requests with Congress

Apr 7, 2026 11:04am
dollar sign pipeline

Biopharma funding fell 20% in 2025: IQVIA

Mar 26, 2026 6:01am
obesity pill

BrightGene's oral drug sees up to 8% weight loss in early data

Mar 25, 2026 4:04am
Closeup of blue eye on black background

Innovent eyes China approval after matching Eylea in phase 3

Mar 24, 2026 6:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings